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Background: Marine microorganisms are considered to be an important source of bioactive molecules against
various diseases and have great potential to increase the number of lead molecules in clinical trials. Progress in
novel microbial culturing techniques as well as greater accessibility to unique oceanic habitats has placed the
marine environment as a new frontier in the field of natural product drug discovery.
Methods: A total of 24 microbial extracts from deep-sea brine pools in the Red Sea have been evaluated for their
anticancer potential against three human cancer cell lines. Downstream analysis of these six most potent extracts
was done using various biological assays, such as Caspase-3/7 activity, mitochondrial membrane potential (MMP),
PARP-1 cleavage and expression of γH2Ax, Caspase-8 and -9 using western blotting.
Results: In general, most of the microbial extracts were found to be cytotoxic against one or more cancer cell lines
with cell line specific activities. Out of the 13 most active microbial extracts, six extracts were able to induce
significantly higher apoptosis (>70%) in cancer cells. Mechanism level studies revealed that extracts from
Chromohalobacter salexigens (P3-86A and P3-86B(2)) followed the sequence of events of apoptotic pathway
involving MMP disruption, caspase-3/7 activity, caspase-8 cleavage, PARP-1 cleavage and Phosphatidylserine (PS)
exposure, whereas another Chromohalobacter salexigens extract (K30) induced caspase-9 mediated apoptosis. The
extracts from Halomonas meridiana (P3-37B), Chromohalobacter israelensis (K18) and Idiomarina loihiensis (P3-37C)
were unable to induce any change in MMP in HeLa cancer cells, and thus suggested mitochondria-independent
apoptosis induction. However, further detection of a PARP-1 cleavage product, and the observed changes in
caspase-8 and -9 suggested the involvement of caspase-mediated apoptotic pathways.
Conclusion: Altogether, the study offers novel findings regarding the anticancer potential of several halophilic
bacterial species inhabiting the Red Sea (at the depth of 1500–2500 m), which constitute valuable candidates for
further isolation and characterization of bioactive molecules.
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Over the last four decades, natural products have played
an important role in drug discovery against cancer, one
of the deadliest diseases in the world and the second
most common cause of death in developed countries.
Almost 47% of the anticancer drugs approved in the last
50 years were either natural products or synthetic mole-
cules inspired by natural products [1]. However, due to* Correspondence: mandeep.kaur@kaust.edu.sa
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stated.high toxicity and undesirable side effects associated with
cancer drugs and, in particular, due to the development
of resistance to chemotherapeutic drugs, there is a con-
tinuous need for novel drugs with greater therapeutic
efficiency and/or with fewer side effects [2].
Marine microorganisms are considered to be an import-
ant source of bioactive molecules against various diseases
and have great potential to increase the number of lead
molecules in clinical trials. Approximately 3000 natural
products have been isolated from marine microbial/algal
sources and are described in Antibase [3]. Several of thesetd. This is an Open Access article distributed under the terms of the Creative
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trials for the treatment of various cancers [4,5]. Two
cyanobacteria-derived antimicrotubule agents, i.e. dolasta-
tin A and curacin A have been clinically evaluated against
cancer and served as a lead structure for the synthesis of
number of synthetic analogs/derivatives [6]. Another com-
pound, salinosporamide A, isolated from a marine-derived
actinomycete, a highly potent irreversible inhibitor of
20S proteasome, was also used in clinical trials as an an-
ticancer agent [7]. Additionally, there is circumstantial
evidence that several lead molecules in the clinical de-
velopment pipeline, thought to originate from higher
marine organisms, may actually be produced by marine
microbes [8].
In the last decade, the deep sea has emerged as a new
frontier in the isolation and screening of natural products,
especially for cancer research [9,10]. With advancements
in technology leading to greater accessibility as well as im-
provements in techniques used to culture microorgan-
isms, deep sea environments are becoming ‘hot spots’ for
new and unexplored chemical diversity for drug discovery
[11]. Approximately 30,000 natural products have been
isolated from marine organisms, yet less than 2% of those
derive from deep-water marine organisms (http://dmnp.
chemnetbase.com/intro/index.jsp). Of these, several cyto-
toxic secondary metabolites isolated from deep sea micro-
organisms have been described in the literature [9,12-14].
In our own efforts in this direction, cytotoxic and apop-
totic potentials of marine halophilic bacteria isolated
from the deep sea brine pools of the Red Sea, a largely
unexplored resource in the area of natural product re-
search, have been described previously [15], including
the first report of cytotoxic activity of ‘Sulfitobacter’.
In the present study, ethyl acetate extracts of 24 marine
bacterial strains, isolated from the deep sea brine pools
of the Red Sea, have been evaluated for their anticancer
potential against HeLa (cervical carcinoma), DU145
(prostate carcinoma), and MCF-7 (breast adenocarcin-
oma) cell lines. The rationale behind choosing the cell
lines lie in the severity and/or prevalence of various
cancers in Saudi Arabia as well as around the world.
The prevalence of breast cancer in the Kingdom of
Saudi Arabia has increased from 10.2% in 2000 to 47.2%
in 2007 [16]. Similarly, a screening program has demon-
strated higher prevalence of prostate cancer [17] in the
Kingdom. Another study anticipated a significant in-
crease in proportion of cervical cancer [18] cases in the
Kingdom. These cells lines are the also among the most
robust cell line models used for in vitro drug screening.
The evaluation of proapoptotic potential of highly cyto-
toxic extracts further revealed six highly potent extracts
that were subjected to more detailed assays to infer the
pathways involved in apoptotic mode of cell death in
cancer cells.Methods
Field sampling
The samples were retrieved from brine-seawater inter-
faces, brine layers, and sediments of deep-sea brine
pools during KAUST Red Sea Expedition 2011. Water
samples were collected using a rosette sampler equipped
with 20 Niskin bottles (10 liter each) and a conductivity-
temperature-depth (CTD) unit for monitoring salinity,
temperature, transmission, and pressure (Idronout S.r.l,
Italy). At each sampling site, approximately 180 litres of
sample were collected and pre-filtered through a 5.0 μm
SMWP membrane (diameter 290 mm; Millipore, Ireland)
to remove suspended particles. A tangential flow filtration
(TFF) system (Pellicon 2 Filter Acrylic Holder, Millipore,
US) was used in order to filter-concentrate the samples.
One liter of each concentrated sample was obtained after
retention through a Durapore 0.1 μm PVDF filter (Pellicon
2 Cassette Filter, Screen type C, size 0.5 m2, Millipore
Corporation, MA, USA). These concentrated samples
were stored in a dark bottle at 4°C, and used as inoculum
for microbial isolations. Sediment collection was per-
formed by deploying a multicore sampling device into the
bottom of the brine pools. The top layer of sediment (ap-
proximately 10 cm) was cut, kept in anoxic containers in
the dark, and were later used as inoculum for microbial
isolations.
Source of bacterial isolates
A total of 24 bacterial strains were successfully isolated
from deep-sea brine pools of the Red Sea. Nineteen of
them were isolated from brine-seawater interfaces, one
strain from brine, and four strains from sediments
(Table 1). The inocula for bacterial isolation were collected
from five different brine pools named Atlantis II (2194 m),
Discovery Deep (2224 m), Kebrit Deep (1573 m), Nereus
Deep (2458 m), and Erba Deep (2395 m) [19]. Each of the
deep-sea brine pools has its unique physicochemical com-
position, with salinity up to 26%, including notably high
temperature, as well as high concentrations of heavy
metals [20]. The Atlantis II Deep and the Discovery deep
are considered as hot brines, with maximum temperatures
67.8°C and 44.8°C, respectively. Brine–seawater boundar-
ies in these brine pools are characterized by strong
temperature and salinity gradients [21].
All of the bacterial strains isolated in this study were
obtained by the streak plate method described elsewhere
[34]. Eighteen strains grew in salinities of 10% NaCl and
the rest of the isolates grew well in salinities of 20% NaCl.
PCR amplification
Nucleic acids were extracted with Qiagen kit (DNeasy
blood & tissue kit, Qiagen, Germany) according to the
instruction manual. PCR amplifications of the extracted
DNA were performed in a 25 μl reaction, each mixture
Table 1 Taxonomic identification and collection location for 24 microbial strains
Isolates Source Closest relative Similarity (16S rRNA genes) Accession number Ref.
P1-16A Kebrit interface Halomonas meridiana 100% AF212217 [22]
P1-16C Kebrit interface Idiomarina loihiensis 98% AE017340 [23]
P1-26A Nereus brine Virgibacillus salarius 98% NR_041270 [24]
P1-5 Kebrit interface Sediminimonas qiaohouensis 99% NR_044577 [25]
P2-13A Kebrit sediment Chromohalobacter salexigens 99% CP000285 [26]
P2-13B Kebrit sediment Halobacillus halophilus 99% HE717023 [27]
P2-16A Kebrit interface Halomonas meridiana 99% AF212217 [22]
P3-16A Kebrit interface Halomonas meridiana 99% AF212217 [22]
P3-16B Kebrit interface Halomonas meridiana 99% AF212217 [22]
P3-37A Nereus interface Halomonas meridiana 99% AF212217 [22]
P3-37B Nereus interface Halomonas meridiana 99% AF212217 [22]
P3-37C Nereus interface Idiomarina loihiensis 91% AE017340 [23]
P3-86A Discovery interface Chromohalobacter salexigens 100% CP000285 [26]
P4-13A Kebrit sediment Chromohalobacter salexigens 99% CP000285 [26]
P4-13B Kebrit sediment Staphylococcus sp. 100% JQ082193 [28]
P5-86A Discovery interface Idiomarina baltica 99% NR_027560 [29]
P5-86B Discovery interface Chromohalobacter salexigens 99% CP000285 [26]
P6-86 Discovery interface Chromohalobacter salexigens 99% CP000285 [26]
K-2 Atlantis II interface Zunongwangia profunda 100% NR_074656 [30]
K-18 Atlantis II interface Chromohalobacter israelensis 100% AM945672 [31]
K-30 Atlantis II interface Chromohalobacter salexigens 99% CP000285 [26]
H102 Erba brine interface Marinobacter adhaerens 100% NR_074765 [32]
H105 Erba brine interface Idiomarina zobellii 99% NR_024892 [33]
P3-86B (2) Discovery interface Chromohalobacter salexigens 96% CP000285 [26]
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mega, USA), 1 μl (final concentration 0.5 μM) of
primer 27bF (5′-AGAGTTTGATCMTGGCTCAG-3′)
and 1492uR (5′-TACCTTGTTACGACTT-3′), 8.5 μl
RNAase&DNAase free H2O (Teknova), and DNA tem-
plate. PCR was carried out in Mastercycler (Eppendorf,
Germany) under following conditions: 94°C for 3 min;
35 cycles of 94°C for 60 s, 53°C for 90 s, 72°C for 90 s.
A final extension was done for 7 min at 72°C. The yield
and quality of the PCR products were examined on 1%
(wt/vol) agarose gel (SeaKem GTG, Lonza, USA) stained
with SYBR Safe (Invitrogen, USA). All sequencing re-
actions were purified with Illustra Exostar 1-step (GE,
Healthcare, UK) according to the manufacturer’s protocol.
The 16S rRNA sequences were determined using an ABI
3730xl capillary DNA sequencer (PE Applied Biosystems),
at Core Laboratory KAUST, Saudi Arabia.
Bacterial biomass
The concentrated samples were inoculated onto three
different agar media, plate count agar (Teknova), marine
agar 2216 (Difco), and R2A agar (Oxoid), which were
supplemented with either 10% or 20% NaCl (w/v) toadjust salinity. The plates were incubated at 30°C for up
to three weeks and inspected daily. Colonies from various
agar plates were picked based on difference in colony
morphology. Pure isolates of these colonies were obtained
after three successive transfers to the fresh agar media.
Taxonomic identifications of the isolates were based on
16S rRNA gene sequencing. 16S rRNA gene amplification
and sequencing steps were performed according to [35].
Sequence similarity was analyzed using BLASTN search
program to identify the strains to their closest relatives in
GenBank database (http://www.ncbi.nlm.nih.gov/BLAST).
Bacteria were inoculated in 1 liter of Marine Broth (Difco)
supplemented with NaCl to collect the biomass, and then
were incubated at 30°C in a shaking incubator. After two
weeks of incubation, bacterial cultures were harvested by
centrifugation at ambient temperature for an hour (h).
The centrifugation step was repeated by adding sterile
water at the same salinity to wash the pellets. Cell pellets
were stored at −80°C until used for extract preparation.
Extract preparation
Ethyl acetate extracts of 24 strains of marine bacteria were
prepared at a concentration of 100 mg/mL (speedvac dried
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ultra-sound probe (Biologics Inc., Model 150 V/T) for 5 ×
2 minutes on ice. The solutions were centrifuged at
10000 g for 15 minutes; the supernatants were recovered
and stored at −20°C.Cell culture
MCF-7 (Breast Adenocarcinoma), HeLa (Cervical carcin-
oma), and DU145 (Prostate carcinoma) were obtained
from the American Type Cell Culture Collection (ATCC,
Manassas, VA). All cell lines were cultured in DMEM
(Dulbecco’s Modified Eagle’s Medium), supplemented with
10% FCS (Fetal calf serum), penicillin (100 U/mL) and
streptomycin (100 μg/mL) at 5% CO2 in a 37°C incubator.MTT assay
The cytotoxicity of marine bacterial extracts was esti-
mated by MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide) assay. Cells were seeded
at a density of 2.5 × 103 cells per well in a 384-well cul-
ture plates and treated with 200 and 500 μg/mL marine
bacterial extracts for 48 h. Following incubation with
extracts, 5 μL of sterile MTT (5 mg/mL) dissolved in
PBS was added to each well and incubated with cells for
4 h followed by the addition of 30 μL of solubilization
solution (10% SDS, 10 mM HCl), which was further
incubated with cells for 16 h at 37°C. The OD (optical
density) of each well was measured at 595 nm using a
microtiter plate reader (BMG Labtech PHERAstar FS,
Germany) and results were analyzed using Microsoft
Office Excel©.APOPercentage assay
HeLa cells were seeded in 96-well plates at a density of
5 × 103 cells per well in quadruplicate in 90 μL of media.
After 24 h, cells were treated with marine bacterial ex-
tracts diluted in complete DMEM to a final concentration
of 500 μg/mL and incubated at 37°C for 24 and 48 h. Cells
were treated with 10 mM H2O2 for 30 minutes as a
positive control. The cells were lifted and stained with
APOPercentage dye (Biocolor, UK). Percentage of cells
stained positive for apoptosis was determined with a
high throughput flow cytometer (HTFC) Screening Sys-
tem (IntelliCyt Corporation, Albuquerque, NM). Cells
were gated for FSC-H, SSC-H and in the FL-2H channel
recording a minimum of 1000 events per well.Microscopy
The morphological evaluation and photography of cells
after treatment with extracts was done in 96-well plates
using Primo Vert inverted microscope (Carl Zeiss, Inc.)MMP assay
HeLa cells were seeded in 96-well plates at a density of
5 × 103 cells per well in quadruplicate in 90 μL of media
and allowed to settle overnight. Next day, cells were
treated with 500 μg/mL marine bacterial extracts for 12
and 16 h and stained with 50 μM cyanine dye JC-1
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimi- dazolyl-
carbocyanine iodide, Life Technologies, UK) for 1 h.
Cells were analyzed by HTFC system by plotting FL2-H
vs. FL-1H and applying a quadrant gate to determine
JC-1 aggregates (red) and monomers (green).
Caspase assay
HeLa cells were seeded at a density of 2.5 × 103 cells per
well in 20 μL of media in 384-well plates. After 24 h,
5 μL of marine bacterial extract (500 μg/mL) was added
and incubated for a further 16 h. Caspase-3/7 activity
was estimated using ApoTox-Glo kit (Promega) following
the manufacturer’s instructions. Luminescence was mea-
sured using a luminescence plate reader (BMG Labtech
PHERAstar FS, Germany). The results were normalized to
cell viability (measured using MTT assay).
Western blotting
HeLa cells were seeded at a density of 3 × 105 cells per
well in 6-well plates and left overnight to settle. Cells
were treated with 500 μg/mL of marine bacterial extracts
for 12 and 24 h. Protein was harvested with RIPA lysis
buffer (150 mM NaCl, 1% Triton X 100, 0.1% SDS,
10 mM Tris pH 7.5, 1% sodium deoxycholate) and
quantitated with a BCA protein determination kit
(Pierce Thermo Scientific). 10–20 μg of protein lysate
was subjected to electrophoresis on 12% SDS page gels,
transferred to nitrocellulose membrane and probed with
Caspase-8 (Sigma), Caspase-9 (Thermo Scientific),
PARP-1 (Trevigen) and pH2Aγ (Enzo Life Technologies)
antibodies. β-Tubulin (Santa Cruz) was used as a loading
control.
Z-factor
Z-factor was determined for each assay and a Z-factor
score of ≥0.6 was recorded indicating good to excellent
robustness for assays [36].
Results
Microbial isolates from the Red Sea
Twenty-four strains of marine bacteria were isolated
from the samples collected from brine-seawater interfaces,
brine layers, and sediments of five deep-sea brine pools of
the Red Sea. Taxonomic classification and location of col-
lection for these microbial strains is presented in Table 1.
The samples were extracted by using ethyl acetate and
evaluated for their anticancer potential through various
biological assays.
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The antiproliferative effect of 24 marine bacterial ex-
tracts was evaluated in vitro by MTT assay against three
human cancer cell lines, i.e. DU145 (prostate cancer),
MCF-7 (breast cancer) and HeLa (cervical cancer). The
cancer cells were exposed to marine extracts for 48 h
(Table 2), at the concentrations of 200 and 500 μg/mL.
In general, most of the microbial extracts were able to
induce growth inhibition in one or more cancer cell
line/s; however, extracts P1-5, P2-13B, P3-37B, H-102,
P3-86B and P3-86A displayed up to 60% growth inhib-
ition in DU145 cell line at 500 μg/mL. Similarly in
MCF-7 cells, several microbial extracts were found to
be cytotoxic at the same concentration. HeLa emerged
as the most sensitive cell line as 13 microbial extracts
inhibited 30% or more cell growth at 500 μg/mL concen-
tration (Table 2). Extracts from Halomonas meridiana
(P3-37B) and Chromohalobacter salexigens (K-30 and P3-
86B(2)) displayed the highest growth inhibition, i.e. > 85%.Table 2 Evaluation of antiproliferative effects of marine bacte
Strain HeLa
200 μg/mL 500 μg/mL 200 μg/
P1-16A 8.0 16.2 0
P3-16A 12.9 32.8 0
P5-86B 2.8 2.8 0
H102 54.6 37.0 21.7
P3-16B 0 0 0
P6-86 0 0 0
P2-16A 0 0 0
P1-26A 0 0 0
P5-86A 0 0 0
P3-86B(2) 0 95.2 0
P3-86A 31.9 39.8 32.1
P1-5 27.2 56.3 33.4
P1-16C 30.7 35.3 33.5
H105 17.1 19.0 16.3
P3-37A 1.1 13.6 16.4
K2 1.4 15.5 13.2
P4-13A 0 6.9 4.2
P3-37C 0 4.9 22.1
K18 16.0 36.6 11.6
P3-37B 12.3 43.6 32.5
K30 24.7 28.4 27.9
P2-13B 35.3 50.5 39.5
P4-13B 8.2 8.4 29.0
The growth of cells was inhibited in a dose-dependent manner at concentrations o
hibitory potential of extracts and is presented as percent growth inhibition relative
The extracts selected for apoptosis analysis are presented in bold letters.Microbial extracts with more than 30% growth inhibition
were chosen for further apoptotic analysis. HeLa was
chosen for the downstream analysis of selected microbial
extracts due to its higher sensitivity to most of the
extracts.
Apoptotic cell death in HeLa cells
Since anticancer agents are known to induce apoptosis
in cancer cells and apoptosis biomarkers are being
increasingly used in clinical trials [37], a total of 13
extracts showing significant cytotoxicity were tested for
their proapoptotic potential in HeLa cells by using
APOPercentage assay. Seven extracts were found to
induce apoptosis at 500 μg/mL concentration after
48 h (Figure 1A). Extracts from Chromohalobacter
salexigens (P3-86A, K30, P3-86B(2)), Chromohalobacter
israelensis (K18), Halomonas meridiana (P3-37B) and
Idiomarina loihiensis (P3-37C) induced more thanrial extracts on various cancer cell lines
MCF-7 DU145
























f 200 and 500 μg/mL after 48 h. MTT assay was used to assess the growth in-
to untreated cells. The Z-factor for this experiment was calculated to be 0.76.
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HeLa cells treated with Marine Bacterial Extracts for 48 h
(C)
K30P3-86A K18 P3-86B (2)P3-37BUntx P3-37C
Figure 1 Apoptosis induction in HeLa cells after treatment with marine bacterial extracts. Detection of externalization of PS from cell
membrane was done using APOPercentage assay. Cells were stained with dye and fluorescence was measured using flow cytometry. The
photographs were taken by using inverted microscope. Apoptosis is shown as the percentage of cells that uptake APOPercentage dye relative
to untreated cells. A) Cells were treated with H2O2 or extracts at a final concentration of 500 μg/mL for 48 h, and B) for 24 h. The Z- factor was
calculated to be 0.68 and 0.77 for 48 h and 24 h experiments, respectively. C) The morphology of cancer cells after 24 h of treatment with
chosen extracts.
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tent extracts (P3-86A, K30, P3-37B, K18, 2 and P3-
37C) were also evaluated for apoptosis at 24 h (Fig-
ure 1C), and chosen for further investigation to con-
firm the pathway of induced apoptotic cell death inHeLa cells. The cells were also evaluated for their
morphological features of apoptosis using micros-
copy. Visual inspection showed that the morpho-
logical changes were visible within few hours after
treatment of certain extracts (Figure 1C).
Sagar et al. BMC Complementary and Alternative Medicine 2013, 13:344 Page 7 of 12
http://www.biomedcentral.com/1472-6882/13/344Effects of extracts on MMP
The changes in MMP were used to evaluate its role in
initiating apoptosis. In the present study, MMP was
assessed using JC-1 dye. The JC-1 is a membrane
permeable dye that has a unique characteristic of
attraction to negative charge potential. The electron
transport chain in energized mitochondria (normal
MMP) attracts JC-1 dye into mitochondria where it ac-
cumulates to form J-aggregates (fluoresces red at
595 nm), while mitochondria with disrupted membrane
potential (apoptotic cells) cannot accumulate JC-1, thus
leaving the dye in the monomeric form (fluoresces
green at 530 nm). Extracts from Chromohalobacter
salexigens (P3-86A and P3-86B(2)) were only able to in-
duce changes in MMP by 45% and 29% respectively
(Figure 2) confirming their role in mitochondrial-


























Figure 2 MMP changes in HeLa cells after treatment with marine bac
12 and 16 h and stained with 50 μM JC-1 and analyzed by flow cytometry
of cells (± S.D) with intact (red) or permeable (green) mitochondrial memb
as a positive control. The Z- factor was calculated to be 0.79 and 0.80 for 1Activation of caspases in response to treatment with
extracts
To gain insights into the potential mechanisms of
apoptosis involved, caspase-3/7 activity as well as pro-
tein expression of caspase-8 and −9 were measured for
the six most potent extracts in HeLa cells after 16 h of
treatment. All six extracts were able to activate
caspase-3/7 and can be grouped further into two cat-
egories of ‘active’ and ‘highly active’ depending on the
fold increase in observed caspase-3/7 activity as com-
pared to untreated cells (Figure 3). Microbial extracts
from P3-86A, P3-37B and K18 showed <10 fold in-
crease in caspase-3/7 activity and were termed as
active (in the range of 1.7-6.0 folds) while extracts
from Chromohalobacter salexigens (K30, P3-86B(2))
and Idiomarina loihiensis (P3-37C) were considered

























terial extracts. Cells were treated with 500 μg/mL of each extract for
. Figure presents the 2D plots of FL-2H vs. FL-1H indicating percentage
ranes. Untx represent untreated sample and 100 mM H2O2 was used
2 h and 16 h time points, respectively.
Figure 3 Caspase-3/7 activity in HeLa cells after treatment with
marine bacterial extracts. Cells were treated with 500 μg/mL
extracts for 16 h and caspase-3/7 activity was estimated by measuring
luminescence using ApoTox-Glo kit (Promega). The caspase-3/7 activity
is represented as fold-change in activity when compared to untreated
cells.
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cells. All extracts except Chromohalobacter salexigens
(P3-86A) showed significant reduction in full-length
caspase-9. Similarly, cleavage of caspase-8 (cl-Caspase-8)
was observed in cancer cells treated with all other extracts
except Chromohalobacter salexigens extract (K30).
PARP-1 cleavage through caspases
The concerted action of caspases-3 and -7 lead to
PARP-1 cleavage in response to DNA damaging agents
[38,39] and is considered as a hallmark of apoptosis
[40,41]. To further explore that induced apoptosis in
HeLa cells was via PARP-1 cleavage, western blotting12  24  12  24  12  24  
Untx K30  P3-86A
+ve 12  24  12  24  12  2
Untx P3-86B(2)  K18 
Figure 4 Western blot analysis of PARP-1 cleavage, phosphorylated γ
bacterial extracts. Protein lysates of HeLa cells treated with 500 μg/mL of
probing for cleaved PARP-1 (cl-PARP-1), procaspase-9, cleaved caspase-8 an
positive (+ve) control, Untx represent untreated control and β-tubulin waswas performed. Figure 4 shows an elevation in the
cleaved fragment of PARP-1 (85 kDa) in a time
dependent manner for the extracts from Chromohalobacter
salexigens (P3-86B(2)), Chromohalobacter israelensis (K18),
Halomonas meridiana (P3-37B) and Idiomarina loihiensis
(P3-37C). The PARP-1 cleavage is quite significant after
12 h of treatment; however only a cleaved fragment was
noticeable for these extracts (except for P3-37B) at 24 h.
These observations confirmed the involvement of caspases
mediated PARP-1 cleavage in response to the treatment
with these four marine extracts in HeLa cells.
Activation of γH2Ax, a DNA damage marker
γH2Ax is a variant of H2A histone and is phosphorylated
at serine 139 in the presence of DNA double-stand breaks
caused by DNA damage [42] and DNA fragmentation dur-
ing apoptosis [43]. Substantial DNA damage was mea-
sured in HeLa cancer cells within 12 h of treatment with
extracts P3-37B, P3-37C, P3-86B(2) and K18 (Figure 4),
confirming their role as DNA damaging agents.
Discussion
In the present study, 24 extracts of marine bacteria iso-
lated from the deep-sea brine pools of the Red Sea were
evaluated for their cytotoxic effects against three human
cancer cell lines. Out of all, 13 extracts were found to be
significantly active against one or more cancer cell lines
indicating their cell line specific behavior. The cell line
specific activity of the extracts may be due to the presence
of particular secondary metabolites and/or the different
mechanisms of action of programmed cell death prevalent
in different cancer cell lines.
Apoptosis or programmed cell death in multicellular
organisms maintain the homeostasis by eliminating un-
wanted or defective cells [44]. It is well known that ineffi-
cient apoptosis contribute to several human malignancies4  +ve 12  24  12  24  12  24  







H2AX, Caspase-8 and −9 in HeLa cells after treatment with marine
each extract for 12 and 24 h were subjected to western blotting
d γH2Ax. Cells treated with 400 nM docetaxel for 24 h were used as a
used as a loading control.
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that induce cell death via apoptosis is one of the attractive
strategies for chemotherapy [47]. The extracts from Chro-
mohalobacter salexigens (P3-86A, K-30, P3-86B(2)), Halo-
monas meridian (P3-37B), Idiomarina loihiensis (P3-37C)
and Chromohalobacter israelensis (K-18) were found to be
most actively inducing apoptosis in HeLa cells (Figure 1).
These extracts induced either one or more apoptosis re-
lated molecular changes such as cell shrinkage, PS expos-
ure by membrane flipping, caspase-3/7, -8 or -9 activation,
PARP-1 cleavage (representing DNA fragmentation) and
increase in phosphorylation of γH2Ax (indicating DNA
damage). Not much work has been published on the isola-
tion of cytotoxic compounds from these microbial species.
Our group [15] and others [48-50] have shown previously
that Halomonas species produce metabolites that have the
potential to kill cancer cells. Idiomarina loihiensis is an
aerobic heterotrophic bacterium capable of catabolizing
amino acids as a primary energy source [23]. In PubMed,
there are only 10 articles on Idiomarina loihiensis and
most of these focus on describing its isolation and
characterization [51], metabolism [23], and biofilm form-
ing capabilities [52]. No study to date has focused on
evaluating the bioactive potential of this species.
In the present study, extract from Idiomarina loihiensis
(P3-37C) displayed caspase-dependent apoptosis in HeLa
cells where a strong (229 fold) increase in caspase-3/7
activity was observed. Extract from K-18 also induced
caspase-dependent apoptosis in our study, which showed
100% similarity to Chromohalobacter israelensis. Chromo-
halobacter israelensis is a euryhaline halophile shown to
change its concentration of unsaturated fatty acids in
response to change in salt concentration, thus providing
a mechanism for halophiles to tolerate environmental
stresses [53]. Nothing has been reported so far regarding
cytotoxic potential of this strain. Isolates P3-86A, K-30
and P3-86B(2) were found to have high 16 s similarity
with Chromohalobacter salexigens. This is one of the most
investigated strain (out of the four we are reporting here)
as a PubMed search on 15th July 2013 displayed 33Table 3 Summary of the results of PS exposure apoptosis ass
Caspase-8 cleavage, full-length Caspase-9 and γH2Ax protein
tration of extracts




P3-86A + (73.95%) + (1.7)
K30 + (86.74%) + (50.0)
P3-37B + (84.89%) + (4.2)
K18 + (85.85%) + (5.9)
P3-86B
(2)
+ (80.01%) + (282.1)
P3-37C + (84.77%) + (229.7)
‘+’ represents a positive observation, whereas ‘-’represents a negative observation.articles on Chromohalobacter salexigens. The Work to
date has focused broadly on compatible solutes [54-57]
and metabolism [58-61]. To the best of our knowledge,
no attempt has been made to assess the cytotoxicity
potential of these bacteria.
The key objectives of the present study were to estimate
the proapoptotic potential of novel halophytes isolated
from the brine pools of the Red Sea and to shed light on
the mechanism of apoptosis induction in cancer cells. We
investigated the mode of induction of apoptosis by marine
bacterial extracts by targeting the intrinsic and extrinsic
pathways in human cervical cancer cell line (HeLa).
Broadly, apoptosis is known to work through two path-
ways, i.e., mitochondria-mediated intrinsic pathway and
death receptors mediated extrinsic pathway [62]. Intrinsic
pathway is activated by either permeabilization of the
outer membrane of mitochondria leading to disrupted
MMP, or via DNA damage. Both routes activate caspase-9
and consequently lead to activation of caspase-3 [63]. Ex-
trinsic pathway involves interaction of ligands (Fas and
TNF-alpha) to their transmembrane receptors [64], thus
activating caspase-8, which further activates caspase-3 dir-
ectly [65] or by first activating intrinsic pathway followed
by activation of caspase-3 [66]. Intrinsic- and extrinsic-
pathways merge at caspase-3, which further cleaves PARP-
1 and results in apoptosis [67]. The results of pathway
level investigations of the marine bacterial extracts are
summarized in Table 3.
We reveal here that extracts from Chromohalobacter
salexigens (P3-86A and P3-86B(2)) induced MMP dis-
ruption, caspase-3/7 activation, PARP-1 cleavage and PS
exposure. PS externalization represents an early event
during execution phase of apoptosis occurring between
caspases activity and nuclear condensation [68]. Further
investigation into the expression of caspase-8 and −9
determined the cleavage of caspase-8 after treatment
with extract P3-86A, while no change in expression of
full-length caspase-9 was observed, (Figure 4). This
confirms that P3-86A induces apoptosis through extrin-
sic pathway. Extract P3-86B(2) was found to reduceay, Caspase-3/7 activity, MMP changes, PARP-1 and







+ + - - +
- - + + -
- + + + +
- + + + +
+ + + + +
- + + + +
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thus suggesting that both extrinsic and extrinsic pathways
of apoptosis are involved in its mechanism of action. The
extracts from Halomonas meridiana (P3-37B), Chromoha-
lobacter israelensis (K18) and Idiomarina loihiensis (P3-
37C) were unable to induce any change in MMP in
HeLa cancer cells and thus suggest the mitochondrial-
independent apoptotic induction. The expression of
both full-length caspase-8 and −9 was significantly re-
duced thus confirming the involvement of these initi-
ator caspases in apoptosis induction. DNA damage was
also observed in cancer cells which is known to activate
Caspase-9 [69,70] leading to intrinsic apoptosis in the
absence of mitochondrial-mediated pathway. In case of
Chromohalobacter salexigens (K30) extract, in spite of a
50-fold increase in caspase-3/7 activity and PS exter-
nalization, K-30 neither caused any change in MMP nor
cleavage of PARP-1, although a slight increase in γH2Ax
was observed indicating DNA damage. It is well docu-
mented that PARP activity is induced in response to DNA
strand breaks in cells that have been exposed to DNA-
damaging agents [71]. Although it is widely accepted that
PARP is specifically cleaved during apoptosis [72] by
caspase-3 [73] and caspase-7 [74], but studies have also
shown that PARP activity [75], activation of PARP-
cleaving enzymes [76] and cleavage of PARP-1 [77] are not
essential for induction of apoptosis. In another study,
uncleavable PARP has been shown to accelerate apoptosis
and necrosis [78] with possible explanation that unclea-
vable PARP may lead to imbalanced energy pool by de-
pleting NAD + and ATP pools, which further disrupts
MMP, thus releasing proapototic factors from mito-
chondria. In our study, K30 did not disrupt MMP and
hence the above mentioned explanation does not clarify
the mechanism of apoptosis induction by K30. Caspase-
9 was significantly reduced at 24 h after K30 induction.
This suggests that the K30 induces apoptosis in cancer
cells through intrinsic pathway where DNA damage
leads to activation of caspase-9 that further contributes
to the observed activities of caspase-3/7 and PS exposure.
In the last decade, phosphorylated gamma-H2AX
(γH2Ax) has emerged as a marker of DNA damage
[79] and drug response in cancer patients [80,81]. The
chemicals/drugs that lead to DNA damage in cells are
known as ‘genotoxic drugs’. Several genotoxic compounds
such as cisplatin, carboplatin, oxaliplatin, methotrexate,
doxorubicin, daunorubicin etc., are currently being used
in the treatment of various types of cancers [82]. The
extracts tested in the present study also showed strong
DNA damage as measured using γH2Ax, which shows
that these extracts may contain compounds that could
find potential therapeutic use in cancer patients. This
study opens up avenues for identifying new DNA dam-
aging compounds from deep-sea bacteria.Conclusions
This study reports for the first time the cytotoxic activities
of several halophilic bacterial species isolated from deep
sea brine pools of the Red Sea and provides in-depth in-
sights into the possible mechanisms of apoptosis induced
by the extracts in various human cancer cell lines. Overall,
six extracts from Chromohalobacter salexigens (P3-86A,
K-30, P3-86B(2)), Halomonas meridian (P3-37B), Idiomar-
ina loihiensis (P3-37C), and Chromohalobacter israelensis
(K-18) have displayed significant anticancer activities and
can be further explored for isolation and characterization
of bioactive molecules. This study also provides conclu-
sive evidence that brine pools of the Red sea harbor sev-
eral species of bacteria producing anticancer secondary
metabolites.
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